Skip to content

Efficiency, Predictability and Security of the Trans-epithelial Photorefractive Keratectomy

Efficiency, Predictability and Security of the Trans-epithelial Photorefractive Keratectomy (Trans-PRK) for Low and Medium Myopia and Astigmatism: Retrospective Study About 118 Eyes

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02893592
Acronym
MYOPAS
Enrollment
118
Registered
2016-09-08
Start date
2015-10-31
Completion date
2016-03-31
Last updated
2016-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopia

Brief summary

The photorefractive keratectomy was the first correction mode refractive laser. It's a photo-ablation of a predetermined thickness of anterior corneal stroma. Debridement of epithelium can be done either mechanically (m-PRK) or by laser (trans-PRK). Trans-PRK has a lot of interests: facility and speed of procedure as well as suppression of human variable. Very good results are obtained by m-PRK. The aim of this study is to show equivalence or non inferiority of trans-PRK over conventional m-PRK in terms of safety and refractive efficiency

Interventions

None listed

Sponsors

Centre Hospitalier Régional Metz-Thionville
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* patients with stable refractive error (more than 2 years) * Myopia up to -4.00 diopters and astigmatism up to -3.00 diopters

Exclusion criteria

* Phototherapeutic keratectomy (PTK)

Design outcomes

Primary

MeasureTime frameDescription
visual acuityMonth 2LogMar

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026